Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes
J. Clin. Invest. Roberto Piva, et al. 116:3171
doi:10.1172/JCI29401 [Go to this article.]

Problems with a PDF?